Santi Aldama
#7PF · Memphis Grizzlies
Fan Verdict
Grade this player:
Career StatsB-
| Year | GP | PPG | RPG | APG | SPG | BPG | FG% | 3PT% | FT% |
|---|---|---|---|---|---|---|---|---|---|
| Career | 278 | 10.4 | 5.4 | 2.1 | 0.7 | 0.6 | 46.3% | 34.6% | 68.6% |
| 2025-26 | 43 | 14.0 | 6.7 | 2.9 | 0.9 | 0.7 | 47.9% | 35.0% | 66.7% |
| 2024-25 | 4 | 13.0 | 6.0 | 1.8 | 0.0 | 0.3 | 47.7% | 41.7% | 0.0% |
| 2023-24 | 61 | 10.7 | 5.8 | 2.3 | 0.7 | 0.9 | 43.5% | 34.9% | 62.1% |
Current Contract
Length
3 years
Total Value
$35.5M
AAV
$11.8M/yr
Contract Value Index (CVI)
Santi Aldama's contract with the Memphis Grizzlies grades out as an above-average value contract, earning a B- CVI grade. At $11.8M per year over 3 years, this is a role player contract. Santi's deal falls in the role player tier for NBA Power Forwards. At 25 years old, Santi is in or near prime years, which supports the investment. The front office found good value in the open market with this signing. This contract should provide positive value over its duration if performance holds steady.
Performance Analysis
Santi Aldama earns a B- Performance grade, reflecting above-average production for a Power Forward. Across 278 career games, Santi has averaged 10.4 points, 5.4 rebounds, and 2.1 assists per game. Santi's strongest metric is FG% at 4631.8, compared to the NBA Power Forward median of 46.0. The biggest area for improvement is APG at 2.1, below the Power Forward median of 4.0. Among 83 NBA Power Forwards graded this season, Santi ranks 16th in overall performance. Santi is a quality starter contributing on both ends for the Memphis Grizzlies.
Current Sentiment
Aldama's injury issues overshadow his potential, creating cautious optimism mixed with durability concerns. On-court production shows promise but inconsistency, with B-minus grades reflecting untapped talent. His $11.8M contract feels reasonable if healthy, but repeated absences raise value questions. NBPA role boosts profile, yet season-ending surgeries dominate narrative over performance. Fans remain hopeful but wary—potential exists, but health reliability remains the defining issue.
Transaction History
No transactions found for this player.